Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Oct. 4, 2023
Abstract
Osteoarthritis
(OA)
is
a
prevalent
joint
disease
that
affects
all
the
tissues
within
and
currently
lacks
disease-modifying
treatments
in
clinical
practice.
Despite
potential
of
rapamycin
for
OA
alleviation,
its
application
hindered
by
challenge
achieving
therapeutic
concentrations,
which
necessitates
multiple
injections
per
week.
To
address
this
issue,
was
loaded
into
poly(lactic-co-glycolic
acid)
nanoparticles
(RNPs),
are
nontoxic,
have
high
encapsulation
efficiency
exhibit
sustained
release
properties
treatment.
The
RNPs
were
found
to
promote
chondrogenic
differentiation
ATDC5
cells
prevent
senescence
caused
oxidative
stress
primary
mouse
articular
chondrocytes.
Moreover,
capable
alleviate
metabolism
homeostatic
imbalance
chondrocytes
both
monolayer
3D
cultures
under
inflammatory
or
stress.
In
destabilization
medial
meniscus
(DMM)
model,
intra-articular
injection
effectively
mitigated
cartilage
destruction,
osteophyte
formation,
hypertrophy,
synovial
inflammation,
pain.
Our
study
demonstrates
feasibility
using
as
clinically
translational
therapy
progression
post-traumatic
OA.
Graphical
abstract
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 12, 2024
Abstract
Although
stem
cell-based
therapy
has
demonstrated
considerable
potential
to
manage
certain
diseases
more
successfully
than
conventional
surgery,
it
nevertheless
comes
with
inescapable
drawbacks
that
might
limit
its
clinical
translation.
Compared
cells,
cell-derived
exosomes
possess
numerous
advantages,
such
as
non-immunogenicity,
non-infusion
toxicity,
easy
access,
effortless
preservation,
and
freedom
from
tumorigenic
ethical
issues.
Exosomes
can
inherit
similar
therapeutic
effects
their
parental
cells
embryonic
adult
through
vertical
delivery
of
pluripotency
or
multipotency.
After
a
thorough
search
meticulous
dissection
relevant
literature
the
last
five
years,
we
present
this
comprehensive,
up-to-date,
specialty-specific
disease-oriented
review
highlight
surgical
application
exosomes.
derived
(e.g.,
embryonic,
induced
pluripotent,
hematopoietic,
mesenchymal,
neural,
endothelial
cells)
are
capable
treating
encountered
in
orthopedic
neurosurgery,
plastic
general
cardiothoracic
urology,
head
neck
ophthalmology,
obstetrics
gynecology.
The
diverse
cells-derived
hierarchical
translation
tissue-specific
responses,
cell-specific
molecular
signaling
pathways.
In
review,
viable
potent
alternative
managing
various
conditions.
We
recommend
future
research
combines
wisdoms
surgeons,
nanomedicine
practitioners,
cell
researchers
intriguing
area.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(5), P. 2767 - 2767
Published: March 2, 2022
Osteoarthritis
(OA)
is
a
common
degenerative
joint
disease
treated
mostly
symptomatically
before
approaching
its
definitive
treatment,
arthroplasty.
The
rapidly
growing
prevalence
of
OA
highlights
the
urgent
need
for
more
efficient
treatment
strategy
and
boosts
research
into
mechanisms
incidence
progression.
As
multifactorial
disease,
many
aspects
have
been
investigated
as
contributors
to
onset
Differences
in
gender
appear
play
role
natural
history
since
female
sex
known
increase
susceptibility
development.
aim
present
review
investigate
cues
associated
with
by
analyzing
various
hormonal,
anatomical,
molecular,
biomechanical
parameters,
well
their
differences
between
sexes.
Our
findings
reveal
possible
implications
progression
provide
evidence
gaps
current
state
art,
thus
suggesting
future
directions.
Smart Medicine,
Journal Year:
2022,
Volume and Issue:
1(1)
Published: Dec. 1, 2022
Osteoarthritis
(OA)
is
a
common
disease
that
endangers
millions
of
middle-aged
and
elderly
people
worldwide.
Researchers
from
different
fields
have
made
great
efforts
achieved
remarkable
progress
in
the
pathogenesis
treatment
OA.
However,
there
still
no
cure
for
In
this
review,
we
discuss
OA
summarize
current
clinical
therapies.
Moreover,
introduce
various
natural
synthetic
biomaterials
drug
release,
cartilage
transplantation,
joint
lubricant
during
treatment.
We
also
present
our
perspectives
insights
on
future.
hope
review
will
foster
communication
collaboration
among
biological,
clinical,
biomaterial
researchers,
paving
way
therapeutic
breakthroughs.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 17, 2022
Osteoarthritis
(OA)
reduces
the
quality
of
life
as
a
result
pain
caused
by
continuous
joint
destruction.
Inactivated
Lactobacillus
(LA-1)
ameliorated
osteoarthritis
and
protected
cartilage
modulating
inflammation.
In
this
study,
we
evaluated
mechanism
which
live
LA-1
OA.
To
investigate
effect
on
OA
progression,
administered
into
monosodium
iodoacetate
(MIA)-induced
animals.
The
threshold,
damage,
inflammation
synovial
membrane
were
improved
LA-1.
Furthermore,
analysis
intestinal
tissues
feces
in
disease
model
has
been
shown
to
affect
systems
system
improve
microbiome
environment.
Interestingly,
tissue
was
reduced,
altered
Live
administration
led
an
increase
level
Faecalibacterium
is
short-chain
fatty
acid
(SCFA)
butyrate-producing
bacteria.
daily
supply
butyrate,
bacterial
SCFA,
showed
tendency
decrease
necroptosis,
type
abnormal
cell
death,
inducing
autophagy
reversing
impaired
inflammatory
These
results
suggest
that
modulated
changes
gut
microbiome,
suggesting
activation
can
reduce
aberrant
death.
summary,
or
butyrate
ameliorates
progression
environment
autophagic
flux.
Our
findings
regulation
microenvironment
therapeutic
target
for
Cells,
Journal Year:
2022,
Volume and Issue:
11(24), P. 4034 - 4034
Published: Dec. 13, 2022
Articular
cartilage
shows
limited
self-healing
ability
owing
to
its
low
cellularity
and
avascularity.
Untreated
defects
display
an
increased
propensity
degenerate,
leading
osteoarthritis
(OA).
During
OA
progression,
articular
chondrocytes
are
subjected
significant
alterations
in
gene
expression
phenotype,
including
a
shift
towards
hypertrophic-like
state
(with
the
of
collagen
type
X,
matrix
metalloproteinases-13,
alkaline
phosphatase)
analogous
what
eventuates
during
endochondral
ossification.
Present
management
strategies
focus,
however,
exclusively
on
inflammation
degradation.
A
better
understanding
hypertrophic
chondrocyte
phenotype
might
give
new
insights
into
pathogenesis,
suggesting
potential
disease-modifying
therapeutic
approaches.
Recent
developments
field
cellular/molecular
biology
tissue
engineering
proceeded
direction
contrasting
onset
this
but
knowledge
gaps
cause–effect
these
processes
still
present.
In
review
we
will
highlight
possible
advantages
drawbacks
using
approach
as
strategy
while
focusing
experimental
models
necessary
for
phenomenon.
Specifically,
discuss
brief
cellular
signaling
pathways
associated
with
progression
analyze
depth
disadvantages
various
that
have
been
used
mimic
it.
Afterwards,
present
developed
proposed
impede
hypertrophy
mineralization/calcification.
Finally,
examine
future
perspectives
strategies.
Asian Journal of Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
18(5), P. 100845 - 100845
Published: Sept. 1, 2023
RNA
interference
(RNAi)
using
small
interfering
(siRNA)
has
shown
potential
as
a
therapeutic
option
for
the
treatment
of
arthritis
by
silencing
specific
genes.
However,
siRNA
delivery
faces
several
challenges,
including
stability,
targeting,
off-target
effects,
endosomal
escape,
immune
response
activation,
intravascular
degradation,
and
renal
clearance.
A
variety
nanotherapeutics
like
lipidic
nanoparticles,
liposomes,
polymeric
solid
lipid
nanoparticles
have
been
developed
to
improve
cellular
uptake,
protect
it
from
enhance
its
efficacy.
Researchers
are
also
investigating
chemical
modifications
bioconjugation
reduce
immunogenicity.
This
review
discusses
various
immune-mediated
diseases,
rheumatoid
arthritis,
osteoarthritis,
etc.
an
upsurge
interest
future
looks
promising
such
interdisciplinary
approach-based
modalities
that
combine
principles
molecular
biology,
nanotechnology,
formulation
sciences.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2024,
Volume and Issue:
12
Published: Jan. 16, 2024
Osteoarthritis
(OA),
as
a
degenerative
disease,
leads
to
high
socioeconomic
burdens
and
disability
rates.
The
knee
joint
is
typically
the
most
affected
characterized
by
progressive
destruction
of
articular
cartilage,
subchondral
bone
remodeling,
osteophyte
formation
synovial
inflammation.
current
management
OA
mainly
focuses
on
symptomatic
relief
does
not
help
slow
down
advancement
disease.
Recently,
mesenchymal
stem
cells
(MSCs)
their
exosomes
have
garnered
significant
attention
in
regenerative
therapy
tissue
engineering
areas.
Preclinical
studies
demonstrated
that
MSC-derived
(MSC-Exos),
bioactive
factor
carriers,
promising
results
cell-free
OA.
This
study
reviewed
application
various
MSC-Exos
for
treatment,
along
with
exploring
potential
underlying
mechanisms.
Moreover,
strategies
future
perspectives
utilization
engineered
MSC-Exos,
alongside
associated
challenges,
were
also
discussed.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
174, P. 116570 - 116570
Published: April 9, 2024
Copper
is
an
essential
trace
element
in
the
human
body
that
extensively
distributed
throughout
various
tissues.
The
appropriate
level
of
copper
crucial
to
maintaining
life
activities
body,
and
excess
deficiency
can
lead
diseases.
levels
are
regulated
by
homeostasis,
which
maintains
tissues
cells
controlling
its
absorption,
transport,
storage.
Cuproptosis
a
distinct
form
cell
death
induced
excessive
accumulation
intracellular
copper.
homeostasis
cuproptosis
has
recently
elicited
increased
attention
realm
health.
emerged
as
promising
avenue
for
cancer
therapy.
Studies
concerning
osteoarticular
diseases
have
elucidated
intricate
interplay
among
cuproptosis,
onset
dysregulation
cause
abnormal
bone
cartilage
metabolism,
affecting
related
cells.
This
phenomenon
assumes
critical
role
pathophysiological
processes
underpinning
diseases,
with
implications
inflammatory
immune
responses.
While
early
Cu-modulating
agents
shown
promise
clinical
settings,
additional
research
advancements
warranted
enhance
their
efficacy.
In
this
review,
we
summarize
effects
potential
mechanisms
on
cartilage,
well
regulatory
roles
pathological
mechanism
(e.g.,
osteosarcoma
(OS),
osteoarthritis
(OA),
rheumatoid
arthritis
(RA)).
We
also
discuss
clinical-application
prospects
copper-targeting
strategy,
may
provide
new
ideas
diagnosis
treatment
Aging Cell,
Journal Year:
2024,
Volume and Issue:
23(4)
Published: Jan. 29, 2024
Abstract
Osteoarthritis
(OA),
a
chronic
degenerative
joint
disease,
is
highly
prevalent
among
the
aging
population,
and
often
leads
to
pain,
disability,
diminished
quality
of
life.
Although
considerable
research
has
been
conducted,
precise
molecular
mechanisms
propelling
OA
pathogenesis
continue
be
elusive,
thereby
impeding
development
effective
therapeutics.
Notably,
recent
studies
have
revealed
subchondral
bone
lesions
precede
cartilage
degeneration
in
early
stage
OA.
This
marked
by
escalated
osteoclast‐mediated
resorption,
subsequent
imbalances
metabolism,
accelerated
turnover,
decrease
volume,
contributing
significantly
pathological
changes.
While
role
hallmarks
extensively
elucidated
from
perspective
chondrocytes,
their
connection
with
osteoclasts
not
yet
fully
understood.
There
compelling
evidence
suggest
that
age‐related
abnormalities
such
as
epigenetic
alterations,
proteostasis
network
disruption,
cellular
senescence,
mitochondrial
dysfunction,
can
stimulate
osteoclast
activity.
review
intends
systematically
discuss
how
contribute
pathogenesis,
placing
particular
emphasis
on
age‐induced
shifts
It
also
aims
future
probing
into
therapeutic
approaches
targeting
during
aging.